SeaStar Medical Holding (ICU) Receivables (2024 - 2026)
SeaStar Medical Holding's (ICU) quarterly Receivables came in at $179000.0 in Q1 2026, up 58.41% YoY from $113000.0 in Q1 2025, and down 24.47% on a QoQ basis from $237000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Receivables (2024 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 3 years of Receivables data on file, last reported at $179000.0 in Q1 2026.
- Quarterly Receivables rose 58.41% year-over-year to $179000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $179000.0 (up 58.41% YoY) and the FY2025 annual result came in at $237000.0, up 111.61% from the prior year.
- Receivables slipped to $179000.0 in Q1 2026, from $237000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $237000.0 in Q4 2025 to a low of $68000.0 in Q3 2024.
- A 3-year average of $165000.0 and a median of $179000.0 in 2026 frame the typical range for Receivables.
- Annual changes were most pronounced in 2025 — Receivables jumped 225.0% — and 2026, when it surged 58.41%.
- Tracing ICU's Receivables over 3 years: stood at $112000.0 in 2024, then soared by 111.61% to $237000.0 in 2025, then dropped by 24.47% to $179000.0 in 2026.
- The last three Receivables figures came in at $179000.0 (Q1 2026), $237000.0 (Q4 2025), and $221000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 210,000.00 |
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Sep 30, 2025 | 221,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 113,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 68,000.00 |